肾复康对糖尿病肾病尿白蛋白排泄率的影响

近年来,笔者采用自拟肾复康胶囊治疗糖尿病肾病(DN),并观察其对尿白蛋白排泄率的影响,取得良好的效果。现报道如下。1 对象与方法1.1 观察对象:34例患者均来源于本院专科门诊,均经确诊为糖尿病肾病,且病程大于5年,并经中西药治疗血糖、血压已得到控制,空腹血糖≤     

一次性换药盒在伤口敷料渗出中的应用

在腹部外科常常能见到因感染伤口敷料或引流口敷料渗出而污染患者被服的现象，特别是有腹水患者渗出更严重，需要勤更换被服，卧床及危重病人每次更换被服不仅给病人带来痛苦，也给病人带来心理负担，还给护理人员增加了不必要的工作量，而且棉被湿透后难以清洗，为防止这一现象，我们将一次性换药盒做为伤口敷料保护罩，防止被服污染，应用效果满意。     

烧伤创面覆盖物的临床应用现状

<正>皮肤是人体最大的器官,具有抵御外界微生物入侵、排泄及防止水分蒸发、调节体温、维持机体内环境稳定等重要作用, 烧伤后机体发生的局部和全身并发症与丧失皮肤屏障有关。尽早封闭、修复缺损皮肤并最大可能地恢复皮肤功能与外观是烧伤治疗的最终目的。烧伤后若有一个性能优良的创面覆盖物可暂时起到皮肤屏障功能的部分作用,因此,烧伤创面覆盖     

美托康治疗急性脑梗塞的临床观察

目的：观察美托康对急性脑梗塞的疗效及副作用。方法：对2004．2-2005．6在我科住院的95例发病3天以内的急性脑梗塞患者随机分为两组，治疗组52例用美托康250ml静脉滴注，每日一次；对照组43例，给予复方丹参注射液20ml加入生理盐水或5％葡萄糖液250ml．中静脉滴注，每日一次。两组患者治疗14天后，进行疗效评定，并对治疗前后血脂、血液流变学等生化指标进行分析。结果：经过一个疗程，治疗组总有效率为88％，对照组总有效率为67．4％。经x^2检验，p〈0．05，有显著差异。治疗前后分别查血脂，血液流变学明显改善，与治疗组相比有显著差异。结论：美托康能有效改善血液流变学，降低血脂，减少急性缺血性脑血管病人的神经功能缺损，无明显不良反应，是一种有效治疗脑梗塞病的药物。     

HPLC测定肝速康胶囊中齐墩果酸的含量

肝速康胶囊为《卫生部药品标准中药成方制剂》第十三册收载的品种,由齐墩果酸粗品和云芝多糖两味药组成,本品具有降酶,降浊,调整机体免疫功能,改善代谢障碍、肝病症状及加速肝功能恢复等作用,临床上用于急、慢性、迁延性肝炎。本实验以方中主要活性成分齐墩果酸为测定指标,采用高效液相色谱法测定其含量,并经方法学考察,认为本法可行,为该制剂的质量控制提供了快速、准确的测定方法。1仪器与试药仪器:PU-1580高压液相泵,日本JASCO公司UV-1575紫外检测仪,CK色谱王工作站。试药与试剂:齐墩果酸对照品批号为709-9803(中国药品生物制品检定…     

颈椎康中药枕垫治疗颈椎病137例疗效观察

颈椎病是临床常见疾病,病程长,病情反复发作,治疗较为棘手,甚至严重影响工作及生活质量,我们自1999年以来采用自制颈复康中药枕垫治疗颈椎病137例,取得了满意的疗效.现总结报告如下.     

中药“口康”含漱液体外抑菌试验和毒性试验研究

OBJECTIVE: To study the antibacterial activity of Chinese medicine kou-Kang mouthwash and its acute toxicity, and provide the basis of experiment and therapy for infectious diseases of the oral cavity. METHODS: Minimal inhibitory concentrations (MIC) of kou-Kang mouthwash were determined by the agar dilution method, and the acute toxicity was done. RESULTS: The range of MIC kou-Kang mouthwash against 27 Gram negative bacterial were 0.03-1.0 g.ml-1. MIC50 was 0.125 g.ml-1 and MIC90 was 0.125-0.5 g.ml-1. The range of MIC kou-Kang mouthwash against 21 Gram positive bacterial was 0.008-0.5 g.ml-1. The range of MIC50 and MIC90 were 0.015-0.125 g.ml-1 and 0.015-0.5 g.ml-1, respectively. The value of MIC was 0.015 g.ml-1 against candidia albicans. The acute toxic test indicated that the maximum tolerance dose was 417.6 g.kg-1 and 210 times as much as the clinical dose a day. No death of animals or toxicity and side-effect occurred in the test. CONCLUSION: Kou-Kang mouthwash shows a potent antibacterial activity against various pathogens of the oral cavity. Its antibiotic activity against Gram positive bacteria was 2-8 times stronger than that against Gram negative bacteria. It has low toxicity and can be used in clinical application.